Pubblicazioni

Reply to Zaragori et al.: “Is IDH mutation status associated with 18F-FDopa PET uptake”

2020 - ANNALS OF NUCLEAR MEDICINE
Cicone, F.; Carideo, L.; Scaringi, C.; Minniti, G.

Overall survival and progression-free survival in patients with primary brain tumors after treatment: is the outcome of [18F] FDOPA PET a prognostic factor in these patients?

2019 - ANNALS OF NUCLEAR MEDICINE
Chiaravalloti, A.; Esposito, V.; Ursini, F.; Di Giorgio, E.; Zinzi, M.; Calabria, F.; Cimini, A.; Schillaci, O.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma